This revised R13 application requests support for a meeting, entitled Behavior, Biology and Chemistry: Translational Research in Addiction (BBC), to be held annually in San Antonio in 2011-2013. The 2-day meeting continues highly successful BBC meetings in 2009 and 2010 that were attended by a diverse group of addiction researchers, from undergraduate students to senior scientists and encompassing a wide range of disciplines, from molecular biology to psychiatry. BBC meetings receive a high level of financial and institutional support from the hosting university (University of Texas Health Science Center) as well as other universities. This transdisciplinary mixture of junior and senior investigators, pre- and post-graduate students provides role models for young scientists while at the same time gives them an opportunity to present results from their own research in a context where there is a lower threshold for presentation, compared with most national meetings. The transdisciplinary and translational theme of the BBC meeting will foster new scientific initiatives and promote thinking that is outside the constraints of traditional disciplines. The format of the meeting contributes to training a new generation of biomedical researchers and, in the process, provides an intensive exposure to new and exciting topics in addiction research. A single symposium at each meeting will bring together experts in a specific area to provide a state-of-the-art overview of an important issue in addiction research;the remainder of the meeting is open to any topic in addiction biology. The meeting includes open communications (two sessions for student presentations) and a poster session. Invited speakers will make presentations that bridge chemistry, biology and behavior in addiction research.
The specific aims of this meeting are as follows: I) facilitate interactions among chemists, biologists and behavioral scientists, thereby stimulating cross-fertilization of ideas and conceptualizations among disciplines;II) provide an attractive and affordable venue for young scientists, especially underrepresented minorities and women, in the addiction field to present their research and to learn about state-of-the-art research on the behavioral biology of addiction;and III) provide a freely available electronic archive of the plenary symposium and other keynote lectures.

Public Health Relevance

This application requests support to continue a highly successful scientific meeting that brings together students, junior and senior scientists from different disciplines (molecular biology to psychiatry) in order to promote new collaborations and creative transdisciplinary and translational thinking about novel targets for developing medications for addiction. This meeting will promote new scientific initiatives and introduce young scientists, especially underrepresented minorities and women, to cutting-edge research in addiction biology.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Conference (R13)
Project #
1R13DA029347-01A1
Application #
8127298
Study Section
Special Emphasis Panel (ZDA1-GXM-A (04))
Program Officer
Grant, Steven J
Project Start
2011-03-15
Project End
2014-01-31
Budget Start
2011-03-15
Budget End
2012-01-31
Support Year
1
Fiscal Year
2011
Total Cost
$25,000
Indirect Cost
Name
University of Texas Health Science Center San Antonio
Department
Pharmacology
Type
Schools of Medicine
DUNS #
800772162
City
San Antonio
State
TX
Country
United States
Zip Code
78229
Bachtell, Ryan K; Jones, Jermaine D; Heinzerling, Keith G et al. (2017) Glial and neuroinflammatory targets for treating substance use disorders. Drug Alcohol Depend 180:156-170
Grandy, David K; Miller, Gregory M; Li, Jun-Xu (2016) ""TAARgeting Addiction""--The Alamo Bears Witness to Another Revolution: An Overview of the Plenary Symposium of the 2015 Behavior, Biology and Chemistry Conference. Drug Alcohol Depend 159:9-16
Reith, Maarten E A; Blough, Bruce E; Hong, Weimin C et al. (2015) Behavioral, biological, and chemical perspectives on atypical agents targeting the dopamine transporter. Drug Alcohol Depend 147:1-19
De Biasi, M; McLaughlin, I; Perez, E E et al. (2014) Scientific overview: 2013 BBC plenary symposium on tobacco addiction. Drug Alcohol Depend 141:107-17
Zorrilla, Eric P; Heilig, Markus; de Wit, Harriet et al. (2013) Behavioral, biological, and chemical perspectives on targeting CRF(1) receptor antagonists to treat alcoholism. Drug Alcohol Depend 128:175-86
Whistler, Jennifer L (2012) Examining the role of mu opioid receptor endocytosis in the beneficial and side-effects of prolonged opioid use: from a symposium on new concepts in mu-opioid pharmacology. Drug Alcohol Depend 121:189-204
Stockton Jr, Steven D; Devi, Lakshmi A (2012) Functional relevance of ?-? opioid receptor heteromerization: a role in novel signaling and implications for the treatment of addiction disorders: from a symposium on new concepts in mu-opioid pharmacology. Drug Alcohol Depend 121:167-72
Traynor, John (2012) ?-Opioid receptors and regulators of G protein signaling (RGS) proteins: from a symposium on new concepts in mu-opioid pharmacology. Drug Alcohol Depend 121:173-80
Lamb, Kenneth; Tidgewell, Kevin; Simpson, Denise S et al. (2012) Antinociceptive effects of herkinorin, a MOP receptor agonist derived from salvinorin A in the formalin test in rats: new concepts in mu opioid receptor pharmacology: from a symposium on new concepts in mu-opioid pharmacology. Drug Alcohol Depend 121:181-8